Home

Diabetes, Type II

Introduction

Diabetes manifests itself when insulin production is not sufficient to keep blood sugar levels within the normal range, both after meals and in the periods between meals. In type 2 diabetes there is almost always a reduced response to insulin in the tissues (insulin resistance) in addition to a reduced capacity to produce insulin by the pancreatic beta-cells.

Symptoms

The process of development of diabetes takes years. The effects of manifest diabetes can go unnoticed by the patient for a long time and in general about half of the diabetic population in Western societies are undiagnosed. (ref) A visual sign that one is at high risk for diabetes is an elevated waist-hip ratio. Symptoms of established diabetes are increased thirst, increased urinary volume, weight loss, lethargy and increased suceptibility to infections. Later symptoms of untreated diabetes include ketoacidosis, stomach pain, vomiting and coma.

Major long term symptoms and effects of diabetes include retinopathy, neuropathy, nephropathy, congitive dysfunction, foot sores and amputations of limbs.

Research

Prevention of microalbuminuria in patients with type 2 diabetes and hypertension. 1)

Prevention of electrocardiographic left ventricular remodeling by the angiotensin receptor blocker olmesartanMedication taken regularly by patients on the Marshall Protocol for its ability to activate the Vitamin D Receptor. Also known by the trade name Benicar. in patients with type 2 diabetes. 2)

Adenosine is an endogenous metabolite that is released from all tissues and cells including liver, pancreas, muscle and fat, particularly under stress, intense exercise, or during cell damage. 3)

The effects of diabetes on Adenosine A2BR receptor transcription and signaling 4)

Results indicate a relationship between muscular TLR4, p-AMPK and NF-κB content and insulin sensitivity. The study also highlights that in situations of insulin resistance, such as in diabetic subjects, metformin treatment may prevent attenuation of activation of the inflammatory pathway. 5)

Here, we investigated the hypothesis that the activation of the low-affinity adenosine receptor, the A2B receptor (A(2B)R), promotes glucose uptake in neurons and astrocytes, thereby linking brain activity with energy metabolism. 6)

Our results illustrate that macrophage A2bAR signaling is needed and sufficient for relaying the protective effect of the A2bAR against HFD-induced tissue inflammationThe complex biological response of vascular tissues to harmful stimuli such as pathogens or damaged cells. It is a protective attempt by the organism to remove the injurious stimuli as well as initiate the healing process for the tissue. and insulin resistance in mice. 7)

This trial aims to determine the effects of resistant starch (RS) subtype 2 (RS2) on glycemic status, metabolic endotoxemia and markers of oxidative stress. 8)

Among persons at high risk for type 2 diabetes not selected for vitamin D insufficiency, vitamin D3Form of vitamin D made in the skin when exposed to light. Also available in fish and meat. This secosteroid is sometimes converted into 25-D. Also known as cholecalciferol and activated 7-dehydrocholesterol. supplementation at a dose of 4000 IU per day did not result in a significantly lower risk of diabetes than placebo. 9)

Management

Diet and exercise are the traditional lifestyle interventions used to prevent and treat type 2 diabetes. Different components of the diet can affect the course of type 2 diabetes, but a low carbohydrate diet appears to be giving the most significant results. 10) 11) 12)

Both endurance and resistance exercise yield improvements in many aspects of the metabolic derangements in diabetes type II.13)

Sulfonylureas, biguanids, glitazones, GLP-1 analogs, DPP-4 inhibitors and insulin are the main medication groups used to treat type 2 diabetes. These medications have modulation of insulin funcion, increments in insulin sensitivity and increments in insulin production as their main mechanisms of action.

Evidence of infectious cause

Rubella virus-induced diabetes in the hamster. 14)

The congenital rubella syndrome provides the best documentation in humans that a viral infection is associated with the subsequent development of insulin-dependent diabetes mellitus.

RESEARCH HIGHLIGHTS

The presence of bacterial components in blood predicts the onset of diabetes mellitus in a large general population recounts lead author Jacques Amar from the Centre Hospitalier Universitaire in Toulouse, France. The investigators determined the concentration of 16S rDNA in blood at baseline and assessed its relationship with incident diabetes mellitus and obesity over a follow-up period of 9 years.

Linda Koch - comment in Nature reviews: Endocrinology

Abstract

AIMS/HYPOTHESIS:

Evidence suggests that bacterial components in blood could play an early role in events leading to diabetes. To test this hypothesis, we studied the capacity of a broadly specific bacterial marker (16S rDNA) to predict the onset of diabetes and obesity in a general population.

METHODS:

Data from an Epidemiological Study on the Insulin Resistance Syndrome (D.E.S.I.R.) is a longitudinal study with the primary aim of describing the history of the metabolic syndrome. The 16S rDNA concentration was measured in blood at baseline and its relationship with incident diabetes and obesity over 9 years of follow-up was assessed. In addition, in a nested case-control study in which participants later developed diabetes, bacterial phylotypes present in blood were identified by pyrosequencing of the overall 16S rDNA gene content.

RESULTS:

We analysed 3,280 participants without diabetes or obesity at baseline. The 16S rDNA concentration was higher in those destined to have diabetes. No difference was observed regarding obesity. However, the 16S rDNA concentration was higher in those who had abdominal adiposity at the end of follow-up. The adjusted OR (95% CIs) for incident diabetes and for abdominal adiposity were 1.35 (1.11, 1.60), p = 0.002 and 1.18 (1.03, 1.34), p = 0.01, respectively. Moreover, pyrosequencing analyses showed that participants destined to have diabetes and the controls shared a core blood microbiotaThe bacterial community which causes chronic diseases - one which almost certainly includes multiple species and bacterial forms., mostly composed of the Proteobacteria phylum (85-90%).

CONCLUSIONS/INTERPRETATION:

16S rDNA was shown to be an independent marker of the risk of diabetes. These findings are evidence for the concept that tissue bacteria are involved in the onset of diabetes in humans.15)

To what extent microbes contribute to the global diabetes burden, and to what extent antimicrobial therapy can prevent or reverse the disease, has to a limited degree been investigated in clinical trials (see below). However, the finding that obese and diabetic patients have higher levels of lipopolysaccharides (LPS, a bacterial product) in their bodies and that insulin level is correlated with the amount of LPS make a strong argument for infectious cause.16)

Inflammation (which is intimately associated with infection) induced by cytokinesAny of various protein molecules secreted by cells of the immune system that serve to regulate the immune system. 17) 18) 19) leads to insulin resistance.

Abrogation of inflammation ameliorates insulin resistance. 20) 21) 22) 23)

Deletion of the insulin receptor in myeloid cell lines inhibits development of insulin resistance.24)

Further, beta amyloid, which has been identified as an antimicrobial peptide,25) is found in increased amounts in pancreatic beta cells of type 2 diabetics,26) hinting at the presence of microorganisms as a cause of the malfunction and destruction of the beta cells.

“The VDRThe Vitamin D Receptor. A nuclear receptor located throughout the body that plays a key role in the innate immune response. is responsible for expression of the Insulin receptor substrate (reference needed). Fix the VDR dysfunction and you will stymy the diabetes. In addition, those of our members who have had high blood-glucose levels have not suffered from having those high BG levels to the same extent that a 'normal' individual would have done, as the VDR activation, and the Angiotensin receptor blockade, both produced by the Olmesartan, have protected their bodies from the expected damage.” Trevor Marshall

Antimicrobial therapy in insulin resistance/type 2 diabetes

Helicobacter pylori eradication led to a reduction in insulin resistance27). The use of oxytetracycline in obese mice reduced insulin resistance28)

Diabetes can cause a sugar coating that smothers body's immune defences 29)

The researchers looked at the similarities in chemical structure between glucose in blood and body fluids, and two other sugar called mannose and fucose. These sugars are found on the surfaces of bacteria and fungi and act as targets for receptors in our body that have evolved to detect and bind to microbial sugars to then combat the infection.

The research found that high levels of glucose outcompetes the binding of mannose and fucose to the specialized immune receptors, potentially blocking these receptors from detecting infectious bacteria and fungi. Glucose also binds in such a way that it inhibits the chemical processes that would normally then follow to combat infections.

Our findings offer a new perspective on how high glucose can potentially affect immunity and thus exert a negative impact on health. It also helps to emphasize the importance of good diet on preventing or controlling diseases such as diabetes. We will build on these ideas in order to consolidate the disease model and to investigate new routes to treatment and prevention.

Burden of Infection and Insulin Resistance in Healthy Middle-Aged Men

Helicobacter pylori Infection Significantly Increases Insulin Resistance in the Asymptomatic Japanese Population

Patient interviews

Chris Eastlund

diabetes, sarcoidosis, irritable bowel syndrome

Read the interview


Interviews of patients with other diseases are also available.

Patients experiences

My blood sugar is back to normal readings, now, too with my latest A1C at 5.2 with no Metformin! I will document that change in my profile…I'm thrilled with my progress! With graditude, Sue

Sue Lyons, MarshallProtocol.com

1)
Menne J, Izzo JLJ, Ito S, Januszewicz A, Katayama S, Chatzykirkou C, Mimran A, Rabelink TJ, Ritz E, Ruilope LM, Rump LC, Viberti G, Haller H, ROADMAP investigators. Prevention of microalbuminuria in patients with type 2 diabetes and hypertension. J Hypertens. 2012 Apr;30(4):811-8; discussion 818. doi: 10.1097/HJH.0b013e328351856d.
[PMID: 22418908] [DOI: 10.1097/HJH.0b013e328351856d]
2)
Raff U, Ott C, Ruilope LM, Menne J, Haller H, Schmieder RE. Prevention of electrocardiographic left ventricular remodeling by the angiotensin receptor blocker olmesartan in patients with type 2 diabetes. J Hypertens. 2014 Nov;32(11):2267-76; discussion 2276. doi: 10.1097/HJH.0000000000000313.
[PMID: 25275251] [DOI: 10.1097/HJH.0000000000000313]
3)
Koupenova M, Ravid K. Adenosine, adenosine receptors and their role in glucose homeostasis and lipid metabolism. J Cell Physiol. 2013 Mar 4:10.1002/jcp.24352. doi: 10.1002/jcp.24352.
[PMID: 23460239] [PMCID: 3849123] [DOI: 10.1002/jcp.24352]
4)
Figler RA, Wang G, Srinivasan S, Jung DY, Zhang Z, Pankow JS, Ravid K, Fredholm B, Hedrick CC, Rich SS, Kim JK, LaNoue KF, Linden J. Links between insulin resistance, adenosine A2B receptors, and inflammatory markers in mice and humans. Diabetes. 2011 Feb;60(2):669-79. doi: 10.2337/db10-1070.
[PMID: 21270276] [PMCID: 3028369] [DOI: 10.2337/db10-1070]
5)
Peixoto LG, Teixeira RR, Vilela DD, Barbosa LN, Caixeta DC, Deconte SR, de Assis de Araújo F, Sabino-Silva R, Espindola FS. Metformin attenuates the TLR4 inflammatory pathway in skeletal muscle of diabetic rats. Acta Diabetol. 2017 Oct;54(10):943-951. doi: 10.1007/s00592-017-1027-5. Epub 2017 Aug 9.
[PMID: 28791487] [DOI: 10.1007/s00592-017-1027-5]
6)
Lemos C, Pinheiro BS, Beleza RO, Marques JM, Rodrigues RJ, Cunha RA, Rial D, Köfalvi A. Adenosine A2B receptor activation stimulates glucose uptake in the mouse forebrain. Purinergic Signal. 2015 Dec;11(4):561-9. doi: 10.1007/s11302-015-9474-3. Epub 2015 Oct 7.
[PMID: 26446689] [PMCID: 4648789] [DOI: 10.1007/s11302-015-9474-3]
7)
Johnston-Cox H, Eisenstein AS, Koupenova M, Carroll S, Ravid K. The macrophage A2B adenosine receptor regulates tissue insulin sensitivity. PLoS One. 2014 Jun 3;9(6):e98775. doi: 10.1371/journal.pone.0098775. eCollection 2014.
[PMID: 24892847] [PMCID: 4043770] [DOI: 10.1371/journal.pone.0098775]
8)
Syntax error [pubmed plugin]
9)
Pittas AG, Dawson-Hughes B, Sheehan P, Ware JH, Knowler WC, Aroda VR, Brodsky I, Ceglia L, Chadha C, Chatterjee R, Desouza C, Dolor R, Foreyt J, Fuss P, Ghazi A, Hsia DS, Johnson KC, Kashyap SR, Kim S, LeBlanc ES, Lewis MR, Liao E, Neff LM, Nelson J, O'Neil P, Park J, Peters A, Phillips LS, Pratley R, Raskin P, Rasouli N, Robbins D, Rosen C, Vickery EM, Staten M, D2d Research Group. Vitamin D Supplementation and Prevention of Type 2 Diabetes. N Engl J Med. 2019 Aug 8;381(6):520-530. doi: 10.1056/NEJMoa1900906. Epub 2019 Jun 7.
[PMID: 31173679] [PMCID: 6993875] [DOI: 10.1056/NEJMoa1900906]
10)
Westman EC, Yancy WSJ, Mavropoulos JC, Marquart M, McDuffie JR. The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus. Nutr Metab (Lond). 2008 Dec 19;5:36. doi: 10.1186/1743-7075-5-36.
[PMID: 19099589] [PMCID: 2633336] [DOI: 10.1186/1743-7075-5-36]
11)
Haimoto H, Sasakabe T, Wakai K, Umegaki H. Effects of a low-carbohydrate diet on glycemic control in outpatients with severe type 2 diabetes. Nutr Metab (Lond). 2009 May 6;6:21. doi: 10.1186/1743-7075-6-21.
[PMID: 19419563] [PMCID: 2690585] [DOI: 10.1186/1743-7075-6-21]
12)
Accurso A, Bernstein RK, Dahlqvist A, Draznin B, Feinman RD, Fine EJ, Gleed A, Jacobs DB, Larson G, Lustig RH, Manninen AH, McFarlane SI, Morrison K, Nielsen JV, Ravnskov U, Roth KS, Silvestre R, Sowers JR, Sundberg R, Volek JS, Westman EC, Wood RJ, Wortman J, Vernon MC. Dietary carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal. Nutr Metab (Lond). 2008 Apr 8;5:9. doi: 10.1186/1743-7075-5-9.
[PMID: 18397522] [PMCID: 2359752] [DOI: 10.1186/1743-7075-5-9]
13)
Praet SFE, van Loon LJC. Optimizing the therapeutic benefits of exercise in Type 2 diabetes. J Appl Physiol (1985). 2007 Oct;103(4):1113-20. doi: 10.1152/japplphysiol.00566.2007. Epub 2007 Jul 26.
[PMID: 17656625] [DOI: 10.1152/japplphysiol.00566.2007]
14)
Rayfield EJ, Kelly KJ, Yoon JW. Rubella virus-induced diabetes in the hamster. Diabetes. 1986 Nov;35(11):1278-81. doi: 10.2337/diab.35.11.1278.
[PMID: 3530856] [DOI: 10.2337/diab.35.11.1278]
15)
Amar J, Serino M, Lange C, Chabo C, Iacovoni J, Mondot S, Lepage P, Klopp C, Mariette J, Bouchez O, Perez L, Courtney M, Marre M, Klopp P, Lantieri O, Doré J, Charles MA, Balkau B, Burcelin R, D.E.S.I.R. Study Group. Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept. Diabetologia. 2011 Dec;54(12):3055-61. doi: 10.1007/s00125-011-2329-8.
[PMID: 21976140] [DOI: 10.1007/s00125-011-2329-8]
16)
Creely SJ, McTernan PG, Kusminski CM, Fisher fM, Da Silva NF, Khanolkar M, Evans M, Harte AL, Kumar S. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab. 2007 Mar;292(3):E740-7. doi: 10.1152/ajpendo.00302.2006. Epub 2006 Nov 7.
[PMID: 17090751] [DOI: 10.1152/ajpendo.00302.2006]
17)
Tateya S, Tamori Y, Kawaguchi T, Kanda H, Kasuga M. An increase in the circulating concentration of monocyte chemoattractant protein-1 elicits systemic insulin resistance irrespective of adipose tissue inflammation in mice. Endocrinology. 2010 Mar;151(3):971-9. doi: 10.1210/en.2009-0926. Epub 2010 Jan 7.
[PMID: 20056828] [DOI: 10.1210/en.2009-0926]
18)
Senn JJ, Klover PJ, Nowak IA, Mooney RA. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes. 2002 Dec;51(12):3391-9. doi: 10.2337/diabetes.51.12.3391.
[PMID: 12453891] [DOI: 10.2337/diabetes.51.12.3391]
19)
Permana PA, Menge C, Reaven PD. Macrophage-secreted factors induce adipocyte inflammation and insulin resistance. Biochem Biophys Res Commun. 2006 Mar 10;341(2):507-14. doi: 10.1016/j.bbrc.2006.01.012. Epub 2006 Jan 13.
[PMID: 16427608] [DOI: 10.1016/j.bbrc.2006.01.012]
20)
Ilan Y, Maron R, Tukpah A, Maioli TU, Murugaiyan G, Yang K, Wu HY, Weiner HL. Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice. Proc Natl Acad Sci U S A. 2010 May 25;107(21):9765-70. doi: 10.1073/pnas.0908771107. Epub 2010 May 5.
[PMID: 20445103] [PMCID: 2906892] [DOI: 10.1073/pnas.0908771107]
21)
Meeter K, Veldkamp R, Tijssen JG, van Herwerden LL, Bos E. Clinical outcome of single versus sequential grafts in coronary bypass operations at ten years' follow-up. J Thorac Cardiovasc Surg. 1991 Jun;101(6):1076-81.
[PMID: 2038201]
22)
Lu M, Patsouris D, Li P, Flores-Riveros J, Frincke JM, Watkins S, Schenk S, Olefsky JM. A new antidiabetic compound attenuates inflammation and insulin resistance in Zucker diabetic fatty rats. Am J Physiol Endocrinol Metab. 2010 May;298(5):E1036-48. doi: 10.1152/ajpendo.00668.2009. Epub 2010 Feb 16.
[PMID: 20159859] [PMCID: 2867370] [DOI: 10.1152/ajpendo.00668.2009]
23)
DeFuria J, Bennett G, Strissel KJ, Perfield JW2, Milbury PE, Greenberg AS, Obin MS. Dietary blueberry attenuates whole-body insulin resistance in high fat-fed mice by reducing adipocyte death and its inflammatory sequelae. J Nutr. 2009 Aug;139(8):1510-6. doi: 10.3945/jn.109.105155. Epub 2009 Jun 10.
[PMID: 19515743] [PMCID: 2709302] [DOI: 10.3945/jn.109.105155]
24)
Mauer J, Chaurasia B, Plum L, Quast T, Hampel B, Blüher M, Kolanus W, Kahn CR, Brüning JC. Myeloid cell-restricted insulin receptor deficiency protects against obesity-induced inflammation and systemic insulin resistance. PLoS Genet. 2010 May 6;6(5):e1000938. doi: 10.1371/journal.pgen.1000938.
[PMID: 20463885] [PMCID: 2865520] [DOI: 10.1371/journal.pgen.1000938]
25)
Soscia SJ, Kirby JE, Washicosky KJ, Tucker SM, Ingelsson M, Hyman B, Burton MA, Goldstein LE, Duong S, Tanzi RE, Moir RD. The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One. 2010 Mar 3;5(3):e9505. doi: 10.1371/journal.pone.0009505.
[PMID: 20209079] [PMCID: 2831066] [DOI: 10.1371/journal.pone.0009505]
26)
Miklossy J, Qing H, Radenovic A, Kis A, Vileno B, Làszló F, Miller L, Martins RN, Waeber G, Mooser V, Bosman F, Khalili K, Darbinian N, McGeer PL. Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes. Neurobiol Aging. 2010 Sep;31(9):1503-15. doi: 10.1016/j.neurobiolaging.2008.08.019. Epub 2008 Oct 23.
[PMID: 18950899] [PMCID: 4140193] [DOI: 10.1016/j.neurobiolaging.2008.08.019]
27)
Gen R, Demir M, Ataseven H. Effect of Helicobacter pylori eradication on insulin resistance, serum lipids and low-grade inflammation. South Med J. 2010 Mar;103(3):190-6. doi: 10.1097/SMJ.0b013e3181cf373f.
[PMID: 20134372] [DOI: 10.1097/SMJ.0b013e3181cf373f]
28)
Bégin-Heck N, Bourassa M, Heick HM. The effect of oxytetracycline on insulin resistance in obese mice. Biochem J. 1974 Sep;142(3):465-75. doi: 10.1042/bj1420465.
[PMID: 4464837] [PMCID: 1168310] [DOI: 10.1042/bj1420465]
29)
Ilyas R, Wallis R, Soilleux EJ, Townsend P, Zehnder D, Tan BK, Sim RB, Lehnert H, Randeva HS, Mitchell DA. High glucose disrupts oligosaccharide recognition function via competitive inhibition: a potential mechanism for immune dysregulation in diabetes mellitus. Immunobiology. 2011 Jan-Feb;216(1-2):126-31. doi: 10.1016/j.imbio.2010.06.002. Epub 2010 Jul 1.
[PMID: 20674073] [PMCID: 3088832] [DOI: 10.1016/j.imbio.2010.06.002]
home/diseases/diabetes2.txt · Last modified: by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.